State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, PR China.
Platelets. 2011;22(1):39-44. doi: 10.3109/09537104.2010.521601. Epub 2010 Oct 29.
Idiopathic thrombocytopenic purpura (ITP) is an acquired organ-specific autoimmune hemorrhagic disease with many immune dysfunctions. Cytotoxic T lymphocyte antigen 4 (CTLA-4) is a T-lymphocyte surface molecule that can down modulate and terminate immune responses. Recently, several studies have confirmed that some polymorphisms of this gene can influence its expression level, therefore speculating that they might be associated with autoimmune diseases. In order to investigate the role of the CTLA-4 gene in ITP, we investigated -318 and CT60 polymorphisms of the CTLA-4 gene in 186 ITP patients and 162 healthy controls through polymerase chain reaction (PCR)-restriction fragment length polymorphism. No significant differences were revealed in genotypes and allele distributions between the patients with ITP and the controls in both sites. Similar results were observed between the two groups when stratified by first onset age and disease course including acute childhood, chronic childhood, acute adult, and chronic adult. In the conclusion, these two single-nucleotide polymorphisms in CTLA-4 are not associated with susceptibility to ITP in a Chinese population.
特发性血小板减少性紫癜(ITP)是一种获得性器官特异性自身免疫性出血性疾病,存在多种免疫功能紊乱。细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4)是 T 淋巴细胞表面分子,可下调并终止免疫反应。最近的多项研究证实,该基因的某些多态性可能影响其表达水平,因此推测其可能与自身免疫性疾病有关。为了探讨 CTLA-4 基因在 ITP 中的作用,我们通过聚合酶链反应(PCR)-限制性片段长度多态性,对 186 例 ITP 患者和 162 例健康对照者的 CTLA-4 基因-318 位和 CT60 多态性进行了研究。在这两个位点,ITP 患者与对照组在基因型和等位基因分布上均无显著差异。在按首发年龄和病程(包括急性儿童、慢性儿童、急性成人和慢性成人)分层后,两组之间也观察到了相似的结果。综上,在中国人群中,CTLA-4 的这两个单核苷酸多态性与 ITP 的易感性无关。